{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:07:24Z","timestamp":1746331644820,"version":"3.40.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Lamotrigine (LTG)-associated extensive hyperpigmentation is rare and may persist for a long time or even become permanent. LTG-associated cutaneous adverse reaction (CAR) manifests initially as mild maculopapular exanthema (MPE). The first step in CAR therapy is to immediately discontinue the offending LTG for predicting evolution to mild or severe forms not always possible. Here, we present a rare case of LTG-associated extensive hyperpigmentation for delaying the withdrawal of LTG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We describe the case of a female adolescent with a history of depression managed with LTG, who developed a mild MPE. Unfortunately, the patient did not discharge LTG after the occurrence of MPE until 20 days later. Then she developed a residual extensive hyperpigmentation in her trunk and extremities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>After a series of physical examinations and retracing past medical history, she was diagnosed with LTG-associated extensive hyperpigmentation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient refused any treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Nine months later, there still existed residual hyperpigmentation in her trunk and extremities, and the range and color of hyperpigmentation have not changed significantly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This case suggests that LTG may cause not only MPE but also extensive hyperpigmentation. When a patient displays a mild MPE following the initiation of LTG in the outpatient clinic, LTG-associated CAR should not be overlooked as a diagnosis, and early withdrawal of LTG should be considered at first.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039878","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:05:16Z","timestamp":1730138716000},"page":"e39878","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Lamotrigine associated extensive hyperpigmentation: A case report and literature review"],"prefix":"10.1097","volume":"103","author":[{"given":"Keling","family":"Pei","sequence":"first","affiliation":[{"name":"Pharmacy Department, Shandong Mental Health Center Affiliated to Shandong University, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0760-405X","authenticated-orcid":false,"given":"Yuqian","family":"Wu","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Shandong Mental Health Center Affiliated to Shandong University, Jinan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Shandong Electric Power Central Hospital, Jinan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40345-022-00271-7","article-title":"Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials.","volume":"10","author":"Maruki","year":"2022","journal-title":"Int J Bipolar Disord"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(21)00247-6","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/tan.13530","article-title":"HLA-associated antiepileptic drug-induced cutaneous adverse reactions.","volume":"93","author":"Mullan","year":"2019","journal-title":"HLA"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/tan.15045","article-title":"HLA alleles and antiseizure medication-induced cutaneous reactions in Brazil: a case-control study.","volume":"102","author":"Spina Tensini","year":"2023","journal-title":"HLA"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"671572","DOI":"10.3389\/fphar.2021.671572","article-title":"HLA risk alleles in aromatic antiepileptic drug-induced maculopapular exanthema.","volume":"12","author":"Shi","year":"2021","journal-title":"Front Pharmacol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.therap.2023.09.005","article-title":"Cutaneous adverse effects of antiepileptic drugs.","volume":"79","author":"Zgolli","year":"2023","journal-title":"Therapie"},{"key":"R7-20250503","first-page":"1063","article-title":"Lamotrigine induced DRESS syndrome in a child: a case report and literature review.","volume":"8","author":"Lin","year":"2021","journal-title":"Children (Basel)"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.seizure.2014.12.001","article-title":"Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis.","volume":"25","author":"Wang","year":"2015","journal-title":"Seizure"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4088\/JCP.v63n1110","article-title":"Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.","volume":"63","author":"Calabrese","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"Neurology"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1106423","DOI":"10.3389\/fphar.2023.1106423","article-title":"Case report: progressive skin rash and lymphadenopathy associated with lamotrigine-valproic acid combination in a bipolar adolescent.","volume":"14","author":"Duan","year":"2023","journal-title":"Front Pharmacol"},{"key":"R12-20250503","first-page":"17","article-title":"Potentially serious Lamotrigine-related skin rash.","volume":"12","author":"Jan","year":"2007","journal-title":"Neurosciences (Riyadh)"},{"key":"R13-20250503","first-page":"65","article-title":"The new antiepileptic drugs hypersensitivity syndromes-a report of 2 cases.","volume":"8","author":"Wang","year":"2014","journal-title":"J Pediatric Pharmacy"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40257-017-0333-6","article-title":"Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment.","volume":"19","author":"Kaufman","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2007.01109.x","article-title":"Rash from antiepileptic drugs: influence by gender, age, and learning disability.","volume":"48","author":"Alvestad","year":"2007","journal-title":"Epilepsia"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"5371854","DOI":"10.1155\/2018\/5371854","article-title":"Lamotrigine-valproic acid interaction leading to Stevens\u2013Johnson syndrome.","volume":"2018","author":"V\u00e1zquez","year":"2018","journal-title":"Case Rep Med"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jfma.2012.01.012","article-title":"Rapid development of severe skin rash after adding valproic acid in a case of bipolar depression treated with low-dose lamotrigine.","volume":"113","author":"Chou","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jid.2020.11.027","article-title":"Granulysin-based lymphocyte activation test for evaluating drug causality in antiepileptics-induced severe cutaneous adverse reactions.","volume":"141","author":"Chu","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.07.003","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting.","volume":"72","author":"Fowler","year":"2019","journal-title":"Seizure"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1684\/epd.2021.1288","article-title":"Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment.","volume":"23","author":"Tensini","year":"2021","journal-title":"Epileptic Disord"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:20:14Z","timestamp":1746318014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":20,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039878","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}